Healthcare Stock Performance - Yahoo Finance (2024)

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(Qt=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Ft)),notifLabel:document.querySelector(".".concat(Gt))};no(e,n)}))}()}};

POLL Should Tesla shareholders once again bless CEO Elon Musk's pay package proposal?

Healthcare

This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.

Market Cap

6.683T

Market Weight

11.09%

Industries

11

Companies

1206

Healthcare S&P 500 ^GSPC

Advanced Chart

Loading Chart for Healthcare

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

Day Return

Sector

0.33%

S&P 500

0.27%

See Also

Horse shoes and horse shoeing: their origin, history, uses, and abuses/Chapter II - Wikisource, the free online library

YTD Return

Sector

5.57%

S&P 500

12.69%

1-Year Return

Sector

7.98%

S&P 500

25.04%

3-Year Return

Sector

5.27%

S&P 500

26.80%

5-Year Return

Sector

65.07%

S&P 500

86.65%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

All Industries

Drug Manufacturers - General

Healthcare Plans

Medical Devices

Biotechnology

Diagnostics & Research

Medical Instruments & Supplies

Medical Care Facilities

Drug Manufacturers - Specialty & Generic

Medical Distribution

Health Information Services

Pharmaceutical Retailers

Industry	Market Weight	YTD Return
All Industries	100.00%		5.57%
Drug Manufacturers - General	34.90%		14.09%
Healthcare Plans	12.82%		-5.69%
Medical Devices	12.42%		3.21%
Biotechnology	11.66%		0.30%
Diagnostics & Research	11.29%		4.27%
Medical Instruments & Supplies	6.62%		5.60%
Medical Care Facilities	2.96%		15.38%
Drug Manufacturers - Specialty & Generic	2.78%		-1.85%
Medical Distribution	2.38%		11.99%
Health Information Services	1.96%		2.10%
Pharmaceutical Retailers	0.21%		-38.37%

Note: Percentage % data on heatmap indicates Day Return

All Industries

--

Day Return --

Market Weight --

YTD Return --

Drug Manufacturers - General -0.28% Healthcare Plans 0.01% Medical Devices -0.76% Biotechnology 0.23% Medical Care Facilities -1.42% Medical Distribution -0.48% Health Information Services 0.54% Pharmaceutical Retailers -0.00%

<= -3

-2

-1

1

2

>= 3

Largest Companies in This Sector

View More

Name	Last Price	1Y Target Est.	Market Weight	Market Cap	Day Change %	YTD Return	Avg. Analyst Rating
LLY Eli Lilly and Company	865.82	862.31	12.50%	822.88B	+0.09%	+48.53%	Buy
UNH UnitedHealth Group Incorporated	496.22	575.92	6.94%	456.713B	+0.25%	-5.75%	Buy
	146.76	171.95	5.36%	353.204B	-0.25%	-6.37%	Buy
	131.84	142.98	5.07%	333.926B	+0.27%	+20.93%	Buy
ABBV AbbVie Inc.	167.70	183.88	4.50%	296.136B	-1.62%	+8.21%	Buy
TMO Thermo Fisher Scientific Inc.	575.89	626.25	3.34%	219.826B	-0.96%	+8.50%	Buy
DHR Danaher Corporation	261.25	272.09	2.94%	193.504B	-1.29%	+12.93%	Buy
ABT Abbott Laboratories	105.81	125.68	2.80%	184.07B	-1.56%	-3.87%	Buy
AMGN Amgen Inc.	300.70	318.55	2.45%	161.306B	-1.32%	+4.40%	Buy
PFE Pfizer Inc.	28.03	31.46	2.41%	158.835B	-0.14%	-2.64%	Hold

View More

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More

Name	Last Price	Net Assets	Expense Ratio	YTD Return
XLV SPDR Select Sector Fund - Healt	146.36	38.377B	0.09%	+7.32%
VHT Vanguard Health Care ETF	267.01	20.386B	0.10%	+6.51%
IBB iShares Biotechnology ETF	136.81	7.077B	0.45%	+0.71%
	92.46	6.751B	0.35%	+3.55%
IHI iShares U.S. Medical Devices ET	56.08	5.173B	0.40%	+3.91%

View More

Mutual Fund Opportunities

View More

Name	Last Price	Net Assets	Expense Ratio	YTD Return
VGHCX Vanguard Specialized Portfolios	218.09	45.706B	0.29%	+4.29%
VGHAX Vanguard Health Care Fund Admir	91.97	45.706B	0.29%	+4.31%
VHCIX Vanguard HealthCare Index Fund	133.59	20.386B	0.10%	+6.51%
0P00017N5J T. Rowe Price Health Sciences F	92.74	15.399B	0.80%	+5.24%
THISX T. Rowe Price Health Sciences F	94.63	14.643B	0.80%	+7.39%

View More

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

• Analyst Report: Perrigo Company PLC

  Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has over 9,000 employees.

  Rating

  Price Target

  Argus• 13 hours ago

• Market Update: CHD, PRGO, LIN

  The board is red -- and investors appear to be taking a defensive stance -- ahead of Fed and inflation news, all coming out tomorrow. The yield on the 10-year Treasury note is down two basis points to 4.44%. Oil is lower at $77 per barrel. Bitcoin is down 4% at $67,000.

  Argus• 13 hours ago

• Analyst Report: BioMarin Pharmaceutical Inc.

  BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU. Voxzogo (vosoritide) was approved in achondroplasia in 2021. BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2022 and in the US in 2023.

  Rating

  Price Target

  Morningstar• 15 hours ago

• Analyst Report: Novo Nordisk A/S

  With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

  Rating

  Price Target

  Morningstar• 15 hours ago

View More

From the Community

Healthcare News